Key result
Controlled blood pressure reduction with antihypertensive therapy successfully treated hypertension-induced thrombotic microangiopathy, improving platelet counts without requiring plasma exchange.
Case Report (n=1)
No
Hypertension-induced thrombotic microangiopathy can be effectively managed with controlled blood pressure reduction using antihypertensives, avoiding the need for invasive plasma exchange.
No takes yet. Share an insight, caveat, or question.
BP control may suffice initially in hypertension-induced TMA; leaves open confirmation in prospective trials.
Bandaru et al. (2022) conducted a case report in Thrombotic microangiopathy secondary to hypertensive emergency (n=1). Antihypertensive therapy was evaluated on Platelet count and lactate dehydrogenase (LDH) levels. Controlled blood pressure reduction with antihypertensive therapy successfully treated hypertension-induced thrombotic microangiopathy, improving platelet counts without requiring plasma exchange.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: